What are the best treatments for Appendix Cancer?

Treatments for Appendix Cancer are highly personalized based on tumor histology and stage, typically involving surgical intervention, such as cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Because Appendix Cancer is rare, care should be managed by a multidisciplinary team at a specialized high-volume cancer center to optimize outcomes.

What are the primary treatments for Appendix Cancer?

The standard of care for Appendix Cancer depends on whether the disease is localized or has spread to the peritoneum. For low-grade tumors that have spread, surgeons often perform CRS to remove all visible tumors, followed by HIPEC, where heated chemotherapy is circulated within the abdomen to eliminate microscopic cells. For more aggressive or advanced Appendix Cancer, systemic chemotherapy is often utilized.

Which medications are used to treat Appendix Cancer?

Systemic chemotherapy is generally reserved for advanced or high-grade cases. Common regimens include:

• 5-fluorouracil (5-FU) or capecitabine (Xeloda)


• Oxaliplatin (Eloxatin)


• Irinotecan (Camptosar)


• Targeted therapies or immunotherapy, which are increasingly explored in clinical trials for specific genetic mutations found in Appendix Cancer

Which specialists should be on the care team?

Managing Appendix Cancer requires a highly coordinated, multidisciplinary approach. Your core team should include:

• Surgical oncologist specializing in peritoneal surface malignancies


• Medical oncologist with expertise in gastrointestinal or rare cancers


• Pathologist experienced in identifying the specific subtype of Appendix Cancer


• Radiologist for specialized imaging interpretation


• Clinical geneticist to assess for hereditary syndromes

How does treatment effectiveness vary?

Effectiveness varies significantly based on the histological grade (low-grade vs. high-grade) and the presence of mucin (pseudomyxoma peritonei). Patients with the 139 members of our DiseaseMaps community often emphasize that "one size does not fit all." Because Appendix Cancer is biologically heterogeneous, your team must tailor the plan to your specific tumor profile.

Next steps

• Consult with a surgical oncologist at a high-volume center that performs at least 20-30 CRS/HIPEC procedures per year.


• Request a review of your pathology slides by an expert in appendiceal tumors.


• Join the DiseaseMaps.org community to connect with other patients and share experiences.


• Search for active clinical trials on ClinicalTrials.gov that specifically target your tumor's genetic markers.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult your oncology team for personalized treatment decisions.

References

• National Cancer Institute (NCI): Appendix Cancer Treatment Overview


• NIH Genetic and Rare Diseases (GARD) Information Center


• PMP Pals (Patient-led support for Pseudomyxoma Peritonei and Appendix Cancer)


• NORD (National Organization for Rare Disorders)